Loading company…
SilicoLife uses metabolic engineering and synthetic biology to design microorganisms and biosynthetic pathways.
Founded in 2010 and based in Braga, Portugal, SilicoLife develops biotechnology using microorganisms, metabolic engineering, and synthetic biology. Its methods support production of chemicals, food ingredients, and biopolymers, using engineered enzymes and biosynthetic pathways. In December 2022, the company raised EUR 4.9 million in Series A funding from BlueCrow.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in